West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,600
Employees10,600
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,600
Employees10,600

WST Key Statistics

Market cap
20.16B
Market cap20.16B
Price-Earnings ratio
41.74
Price-Earnings ratio41.74
Dividend yield
0.30%
Dividend yield0.30%
Average volume
716.25K
Average volume716.25K
High today
$283.52
High today$283.52
Low today
$278.26
Low today$278.26
Open price
$282.88
Open price$282.88
Volume
589.85K
Volume589.85K
52 Week high
$348.90
52 Week high$348.90
52 Week low
$187.43
52 Week low$187.43

Stock Snapshot

The current West Pharmaceutical Services(WST) stock price is $280.23, with a market capitalization of 20.16B. The stock trades at a price-to-earnings (P/E) ratio of 41.74 and offers a dividend yield of 30.2%.

During the trading session on 2025-12-05, West Pharmaceutical Services(WST) shares reached a daily high of $283.52 and a low of $278.26. At a current price of $280.23, the stock is +0.7% higher than the low and still -1.2% under the high.

Trading volume for West Pharmaceutical Services(WST) stock has reached 589.85K, versus its average volume of 716.25K.

The stock's 52-week range extends from a low of $187.43 to a high of $348.90.

The stock's 52-week range extends from a low of $187.43 to a high of $348.90.

WST News

Simply Wall St 2d
How Strong Results and GLP-1 Demand Tailwinds May Shape West Pharma’s Investment Case

Recently, analysts reiterated a positive outlook on West Pharmaceutical Services after the company reported strong quarterly results and raised its guidance, ci...

How Strong Results and GLP-1 Demand Tailwinds May Shape West Pharma’s Investment Case

Analyst ratings

75%

of 20 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.